Endoscopic Management

Michael C. Bennett; Ricardo Badillo; Shelby Sullivan

doi:10.1016/j.gtc.2016.07.005

Endoscopic Management

Michael C. Bennett, Ricardo Badillo, Shelby Sullivan

Gastroenterology

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Endoscopic bariatric therapy consists of devices or procedures for primary weight loss or weight regain after Roux-en-Y gastric bypass that are placed or done endoscopically. In most cases, they result in less weight loss, but fewer complications than bariatric surgery; and more weight loss than lifestyle therapy or weight loss medications. These therapies are important advances to treat patients with obesity. This article focuses on therapies or devices with US Food and Drug Administration approval or those with current or planned US pivotal trials.

Original language	English
Pages (from-to)	673-688
Number of pages	16
Journal	Gastroenterology Clinics of North America
Volume	45
Issue number	4
DOIs	https://doi.org/10.1016/j.gtc.2016.07.005
State	Published - Dec 1 2016

Keywords

Aspiration therapy
Duodenal-jejunal bypass liner
Endoscopic bariatric therapy
Endoscopic sleeve gastroplasty
Intragastric balloon
Obesity
Primary obesity surgery endoluminal
Transpyloric shuttle

Access to Document

10.1016/j.gtc.2016.07.005

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Endoscopic Management'. Together they form a unique fingerprint.

Cite this

@article{d2867f49ad9542218209ccdde9428edd,

title = "Endoscopic Management",

abstract = "Endoscopic bariatric therapy consists of devices or procedures for primary weight loss or weight regain after Roux-en-Y gastric bypass that are placed or done endoscopically. In most cases, they result in less weight loss, but fewer complications than bariatric surgery; and more weight loss than lifestyle therapy or weight loss medications. These therapies are important advances to treat patients with obesity. This article focuses on therapies or devices with US Food and Drug Administration approval or those with current or planned US pivotal trials.",

keywords = "Aspiration therapy, Duodenal-jejunal bypass liner, Endoscopic bariatric therapy, Endoscopic sleeve gastroplasty, Intragastric balloon, Obesity, Primary obesity surgery endoluminal, Transpyloric shuttle",

author = "Bennett, {Michael C.} and Ricardo Badillo and Shelby Sullivan",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.gtc.2016.07.005",

language = "English",

volume = "45",

pages = "673--688",

journal = "Gastroenterology Clinics of North America",

issn = "0889-8553",

number = "4",

}

TY - JOUR

T1 - Endoscopic Management

AU - Bennett, Michael C.

AU - Badillo, Ricardo

AU - Sullivan, Shelby

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Endoscopic bariatric therapy consists of devices or procedures for primary weight loss or weight regain after Roux-en-Y gastric bypass that are placed or done endoscopically. In most cases, they result in less weight loss, but fewer complications than bariatric surgery; and more weight loss than lifestyle therapy or weight loss medications. These therapies are important advances to treat patients with obesity. This article focuses on therapies or devices with US Food and Drug Administration approval or those with current or planned US pivotal trials.

AB - Endoscopic bariatric therapy consists of devices or procedures for primary weight loss or weight regain after Roux-en-Y gastric bypass that are placed or done endoscopically. In most cases, they result in less weight loss, but fewer complications than bariatric surgery; and more weight loss than lifestyle therapy or weight loss medications. These therapies are important advances to treat patients with obesity. This article focuses on therapies or devices with US Food and Drug Administration approval or those with current or planned US pivotal trials.

KW - Aspiration therapy

KW - Duodenal-jejunal bypass liner

KW - Endoscopic bariatric therapy

KW - Endoscopic sleeve gastroplasty

KW - Intragastric balloon

KW - Obesity

KW - Primary obesity surgery endoluminal

KW - Transpyloric shuttle

UR - http://www.scopus.com/inward/record.url?scp=84995483259&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2016.07.005

DO - 10.1016/j.gtc.2016.07.005

M3 - Review article

C2 - 27837781

AN - SCOPUS:84995483259

VL - 45

SP - 673

EP - 688

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 4

ER -